Search for company
Explore more than 1.3 million company profiles from emerging markets

Lupin Ltd. (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 1,722.80
Volume 77,524
Turnover 133,821,929
Index    CNX 100
Market Bombay Stock Exchange
Ticker 500257
Market Cap Market Cap 772,203,915
52 Week High 2,090.90
52 Week Low 909.30
P/E 42.05
EPS 40.97
Dividend Yield 3.2 (March 31, 2012)
Bookvalue 96,512,600
Enterprise Value 550,395,956
Quote updated on April 27, 2015
Note: data in INR Thousands.
Financials
Select Items to chart them. 2015 Q2
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 115,987,100
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Non-Audited, Consolidated
Source: World's Vest Base, EMIS Company Database.
Company Description

Lupin Ltd. commenced business in the year 1968 to venture as a Transnational Pharmaceutical Company. The Company develops and markets a wide range of generic and branded formulations and APIs for the developed and developing markets of the world. The company's office is located in Mumbai.

More
Main Products

Capsules, Inhalers, Liquids (Injectables), Liquids (Formulations), Injectibles (Liquid), Creams & Powders, Injectible Vials, Tablets, Bulk Drugs (Intermediates),
More

More
Contact Information

Legal Address
159, C.S.T Road,, Kalina, Santacruz (E)
Mumbai; Maharashtra; Map
Postal Code: 400098
Tel: 66402323
Fax: 26528806
Email: investorservices@lupinpharma.com
Website: http://www.lupinworld.com

Full name: Lupin Ltd.

Previous name(s): LUPIN CHEMICALS LTD (1983)

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
IN-CIN: L24100MH1983PLC029442
ISIN CODE : INE326A01029
Incorporation Date: 1983

Basic Information
Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Export-Import
2012: Imports INR 7,301,500.00 Thousands
Import connections ('000)
Total(133,294.27)
PRODTOTAL
2012: Exports INR 30,329,200.00 Thousands
Export connections ('000)
Total(553,681.91)
PRODTOTAL
Key Executives
Ownership Details
Indian Promoters
46.45%
More
Affiliates and related companies
Lupin Holdings BV.
100%
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - India
INR | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.